<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">2984726R</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1011</journal-id>
<journal-id journal-id-type="nlm-ta">Biochem J</journal-id>
<journal-id journal-id-type="iso-abbrev">Biochem. J.</journal-id>
<journal-title-group>
<journal-title>The Biochemical journal</journal-title>
</journal-title-group>
<issn pub-type="ppub">0264-6021</issn>
<issn pub-type="epub">1470-8728</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28626083</article-id>
<article-id pub-id-type="pmc">5594744</article-id>
<article-id pub-id-type="doi">10.1042/BCJ20160616</article-id>
<article-id pub-id-type="manuscript">NIHMS900503</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cellular and disease functions of the Prader-Willi Syndrome gene <italic>MAGEL2</italic></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tacer</surname>
<given-names>Klementina Fon</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Potts</surname>
<given-names>Patrick Ryan</given-names>
</name>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<aff id="A1">Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN 38105-3678</aff>
</contrib-group>
<author-notes>
<corresp id="FN1"><label>*</label>Correspondence: Patrick Ryan Potts, 262 Danny Thomas Pl, Memphis, TN 38105-3678 <email>ryan.potts@stjude.org</email> (901) 595-8791</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>19</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>16</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<day>16</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>16</day>
<month>6</month>
<year>2018</year>
</pub-date>
<volume>474</volume>
<issue>13</issue>
<fpage>2177</fpage>
<lpage>2190</lpage>
<!--elocation-id from pubmed: 10.1042/BCJ20160616-->
<abstract>
<p id="P1">Melanoma antigen L2 (MAGEL2 or MAGE-L2) is a member of the MAGE family of ubiquitin ligase regulators. It is maternally imprinted and often paternally deleted or mutated in the related neurodevelopmental syndromes, Prader-Willi Syndrome (PWS) and Schaaf-Yang Syndrome (SHFYNG). MAGEL2 is highly expressed in the hypothalamus and plays an important role in a fundamental cellular process that recycles membrane proteins from endosomes through the retromer sorting pathway. MAGEL2 is part of a multi-subunit protein complex consisting of MAGEL2, the TRIM27 E3 ubiquitin ligase, and the USP7 deubiquitinating enzyme. The MAGEL2-USP7-TRIM27 (or MUST) complex facilitates the retromer recycling pathway through ubiquitination and activation of the WASH actin nucleation promoting factor. This review provides an overview of the MAGE protein family of ubiquitin ligases regulators and details the molecular and cellular role of MAGEL2 in ubiquitination, actin regulation, and endosomal sorting processes, as well as MAGEL2 implications in PWS and SHFYNG disorders and its physiological functions elucidated through the study of <italic>Magel2</italic> knockout mouse models.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>